Literature DB >> 1849907

Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro.

A Yamaguchi1, T Katagiri, T Ikeda, J M Wozney, V Rosen, E A Wang, A J Kahn, T Suda, S Yoshiki.   

Abstract

The in vitro effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on osteogenic and myogenic differentiation was examined in two clonal cell lines of rat osteoblast-like cells at different differentiation stages, ROB-C26 (C26) and ROB-C20 (C20). The C26 is a potential osteoblast precursor cell line that is also capable of differentiating into muscle cells and adipocytes; the C20 is a more differentiated osteoblastic cell line. Proliferation was stimulated by rhBMP-2 in C26 cells, but inhibited in C20 cells. rhBMP-2 greatly increased alkaline phosphate (ALP) activity in C26 cells, but not in C20 cells. The steady-state level of ALP mRNA was also increased by rhBMP-2 in C26 cells, but not in C20 cells. Production of 3',5'-cAMP in response to parathyroid hormone (PTH) was dose-dependently enhanced by adding rhBMP-2 in both C26 and C20 cells, though the stimulatory effect was much greater in the former. There was neither basal expression of osteocalcin mRNA nor its protein synthesis in C26 cells, but they were strikingly induced by rhBMP-2 in the presence of 1 alpha,25-dihydroxyvitamin D3. rhBMP-2 induced no appreciable changes in procollagen mRNA levels of type I and type III in the two cell lines. Differentiation of C26 cells into myotubes was greatly inhibited by adding rhBMP-2. The inhibitory effect of rhBMP-2 on myogenic differentiation was also observed in clonal rat skeletal myoblasts (L6). Like BMP-2, TGF-beta 1 inhibited myogenic differentiation. However, unlike BMP-2, TGF-beta 1 decreased ALP activity in both C26 and C20 cells. TGF-beta 1 induced neither PTH responsiveness nor osteocalcin production in C26 cells, but it increased PTH responsiveness in C20 cells. These results clearly indicate that rhBMP-2 is involved, at least in vitro, not only in inducing differentiation of osteoblast precursor cells into more mature osteoblast-like cells, but also in inhibiting myogenic differentiation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849907      PMCID: PMC2288971          DOI: 10.1083/jcb.113.3.681

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  41 in total

1.  Osteogenin inhibits proliferation and stimulates differentiation in mouse osteoblast-like cells (MC3T3-E1).

Authors:  S Vukicevic; F P Luyten; A H Reddi
Journal:  Biochem Biophys Res Commun       Date:  1990-01-30       Impact factor: 3.575

2.  Recombinant human bone morphogenetic protein induces bone formation.

Authors:  E A Wang; V Rosen; J S D'Alessandro; M Bauduy; P Cordes; T Harada; D I Israel; R M Hewick; K M Kerns; P LaPan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

3.  Type-beta transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cells.

Authors:  M Noda; G A Rodan
Journal:  Biochem Biophys Res Commun       Date:  1986-10-15       Impact factor: 3.575

4.  Bone morphogenetic protein-induced cartilage development in tissue culture.

Authors:  K Sato; M R Urist
Journal:  Clin Orthop Relat Res       Date:  1984-03       Impact factor: 4.176

5.  Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells.

Authors:  N C Partridge; D Alcorn; V P Michelangeli; B E Kemp; G B Ryan; T J Martin
Journal:  Endocrinology       Date:  1981-01       Impact factor: 4.736

6.  Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily.

Authors:  T K Sampath; J E Coughlin; R M Whetstone; D Banach; C Corbett; R J Ridge; E Ozkaynak; H Oppermann; D C Rueger
Journal:  J Biol Chem       Date:  1990-08-05       Impact factor: 5.157

7.  Localization of types I, II, and III collagen mRNAs in developing human skeletal tissues by in situ hybridization.

Authors:  M Sandberg; E Vuorio
Journal:  J Cell Biol       Date:  1987-04       Impact factor: 10.539

8.  Gene expression during osteogenic differentiation in mandibular condyles in vitro.

Authors:  P G Strauss; E I Closs; J Schmidt; V Erfle
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

9.  OP-1 cDNA encodes an osteogenic protein in the TGF-beta family.

Authors:  E Ozkaynak; D C Rueger; E A Drier; C Corbett; R J Ridge; T K Sampath; H Oppermann
Journal:  EMBO J       Date:  1990-07       Impact factor: 11.598

10.  Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur.

Authors:  M E Joyce; A B Roberts; M B Sporn; M E Bolander
Journal:  J Cell Biol       Date:  1990-06       Impact factor: 10.539

View more
  111 in total

1.  Development and characterization of a mouse floxed Bmp2 osteoblast cell line that retains osteoblast genotype and phenotype.

Authors:  Li-an Wu; Junsheng Feng; Lynn Wang; Yan-dong Mu; Andrew Baker; Kevin J Donly; Stephen E Harris; Mary MacDougall; Shuo Chen
Journal:  Cell Tissue Res       Date:  2011-01-27       Impact factor: 5.249

2.  Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of osteoblast differentiation.

Authors:  Sunhwa Kim; Takako Koga; Miho Isobe; Britt E Kern; Taeko Yokochi; Y Eugene Chin; Gerard Karsenty; Tadatsugu Taniguchi; Hiroshi Takayanagi
Journal:  Genes Dev       Date:  2003-08-15       Impact factor: 11.361

3.  Bone tissue engineering on calcium phosphate-coated titanium plates utilizing cultured rat bone marrow cells: a preliminary study.

Authors:  R J Dekker; J D De Bruijn; I Van Den Brink; Y P Bovell; P Layrolle; C A Van Blitterswijk
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

4.  Chondrogenesis from umbilical cord blood cells stimulated with BMP-2 and BMP-6.

Authors:  Cristiane Sampaio de Mara; A S S Duarte; A R Sartori-Cintra; A C M Luzo; S T O Saad; I B Coimbra
Journal:  Rheumatol Int       Date:  2012-01-12       Impact factor: 2.631

Review 5.  Three dimensional de novo micro bone marrow and its versatile application in drug screening and regenerative medicine.

Authors:  Guanqun Li; Xujun Liu; Qian Du; Mei Gao; Jing An
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

6.  Tenofovir treatment of primary osteoblasts alters gene expression profiles: implications for bone mineral density loss.

Authors:  Iwen F Grigsby; Lan Pham; Louis M Mansky; Raj Gopalakrishnan; Ann E Carlson; Kim C Mansky
Journal:  Biochem Biophys Res Commun       Date:  2010-02-18       Impact factor: 3.575

Review 7.  Transplantation of skin fibroblasts expressing BMP-2 contributes to the healing of critical-sized bone defects.

Authors:  Kazunari Hirata; Akio Mizuno; Akira Yamaguchi
Journal:  J Bone Miner Metab       Date:  2007-01-01       Impact factor: 2.626

8.  alpha7 integrin expressing human fetal myogenic progenitors have stem cell-like properties and are capable of osteogenic differentiation.

Authors:  Nobuaki Ozeki; Moon Lim; Chung-Chen Yao; Mirek Tolar; Randall H Kramer
Journal:  Exp Cell Res       Date:  2006-09-23       Impact factor: 3.905

9.  Square prism micropillars improve osteogenicity of poly(methyl methacrylate) surfaces.

Authors:  O Hasturk; M Ermis; U Demirci; N Hasirci; V Hasirci
Journal:  J Mater Sci Mater Med       Date:  2018-05-02       Impact factor: 3.896

10.  Fibroblast growth factor-2 and bone morphogenetic protein-2 have a synergistic stimulatory effect on bone formation in cell cultures from elderly mouse and human bone.

Authors:  Liisa T Kuhn; Guomin Ou; Lyndon Charles; Marja M Hurley; Craig M Rodner; Gloria Gronowicz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-03-26       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.